Bristol Myers CEO Caforio takes pay cut as ‘human capital’ metric drags down bonus
Bristol Myers Squibb is hoping new launches will offset a wave of forthcoming patent losses for some of its biggest-selling drugs. But in the meantime, CEO Giovanni C...
Continue Reading →
